The present study attempts to determine whether the novel anti-migraine drug sumatriptan has antinociceptive activity in rodents. Sumatriptan had little or no antinociceptive activity against a range of noxious stimuli and we therefore conclude that it is unlikely that the beneficial effects of the drug in treating migraine are due to a non-specific analgesic action.
HumphreyPPAFeniukWPerrenMJConnorHEOxfordAWCoatesIHButinaD.GR43175, a selective agonist for the 5--HT1 -like receptor in dog isolated saphenous vein.Br J Pharmacol1988:194:1123–32.
2.
PerrinVLFärkkiläMGoasguenJDoenickeABrandJTfelt-HansenP.Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine.Cephalalgia1989;9:63–72.
3.
FeniakWHumphreyPPAPerrenMJ.The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetised dogs.Br J Pharmacol1989;96:83–90.
4.
PerrenM JFeniukWHumphreyPPA.The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR43175.Cephalalgia1979;9:41–6.
5.
HumphreyPPAFeniukWPerrenMJOxfordAWBrittainRT.Sumatriptan succinate.Drugs of the Future1989;14:35–9.
6.
TyersMB.A classification of opiate receptors that mediate antinociception in animals.Br J Pharmacol1980;69:503–12.
7.
HyldenJLKWilcoxGL.Intrathecal morphine in mice: a new technique.Eur J Pharmacol1980;67:313–16.
8.
FinneyD J.Statistical methods in biological assay.2nd ed. London:Griffin,1964.
9.
FieldsHLBasbaumAIClantonCHAndersonS[).Nucleus raphé magnus inhibition of spinal cord dorsal horn neurones.Brain Res1977;126:441–53.
10.
ZemlanFPCorriganSAPfaffDW.Noradrenergic and serotonergic mediation of spinal analgesia mechanisms.Eur J Pharmacol1980;61:111–24.
11.
BasbaumAIMorleyNJO'KeefeJClantonCH.Reversal of morphine and stimulus-produced analgesia by subtotal spinal cord lesions.Pair1977;3:43–56.
12.
YakshTL.Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the peri-aqueductal gray.Brain Res1979;160:180–5.
13.
McKearneyJW.Apparent antinociceptive properties of piperazine-type serotonin agonists: trifluoromethyl-phenylpiperazine, chlorophenyl-piperazine and MK-212.Pharmacol Biochem Behav1989;32:657–60.
14.
BradleyPBEngelGFeniukWFozardJRHumphreyPPAMiddlemissDNMylecharaneEJRichardsonBPSaxenaPR.Proposals for the classification and nomenclature of functional receptors for 5--hydroxytryptamine.Neuropharmacology1986;25:563–76.
SchoeffterPHoyerD.How selective is GR43175? Interactions with 5--HT1A, 5--HT1B, 5--HT1C and 5--HT1D receptors.Naunyn Schmiedeberg's Arch Pharmacol1989;340:135–8.
17.
HoyerDMiddlemissDN.Species differences in the pharmacology of terminal 5--HT autoreceptors in mammalian brain.TIPS1989;10:130–2.
18.
SchoeffterPHoyerD.5--hydroxytryptamine 5--HT1B and 5--HT1D receptors mediating inhibition of adenylate cyclase activity.Naunyn Schmiedeberg's Arch Pharmacol1989;340:285–92.
19.
BillDJForsterEAFletcherA.Behavioural effects of GR43175 and other 5--HT1 agonists following central administration in the mouse.Br J Pharmacol1989;96:305P.
20.
MiddlemissDNBremerMESmithSM.A pharmacological analysis of the 5--HT receptors mediating inhibition of 5--HT release in the guinea-pig frontal cortex.Eur J Pharmacol1988;157:101–7.
21.
BaarHABrandJDoenickeAMelchartDLübenVTrybaMSahlenderHM.Treatment of acute migraine with subcutaneous GR43175 in West Germany.Cephalalgia1989;9:83–7.
22.
DallasFFADixonCMMcCullochR JSaynorDA.The kinetics of [14 C]-GR43175 in rat and dog.Cephalalgia1989;89:53–6.
23.
HumphreyPPAFeniukWPerrenMJ.5--HT in migraine: evidence from 5--HT1 -like receptor agonists for a vascular aetiology. In:SandlerMCollinsGM. eds.Migraine: a spectrum of ideas.Oxford University Press,1990:147–72.
